Zdrowie i gospodarka · 03/01/2006

FDA Approves Supplemental New Animal Drug Application for Monensin Type C Medicated Feeds

The Food and Drug Administration (FDA) is updating its animal drug regulations to reflect the approval of a supplemental new animal drug application (NADA) filed by Elanco Animal Health. The supplemental NADA revises the description of cattle fed monensin Type C medicated feeds to improve weight gain and prevent coccidiosis.